Standout Papers

HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product 1986 2026 1999 2012 433
  1. HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product (1987)
    Bruno Guy, Yves Rivière et al. Nature
  2. AIDS virus env Protein Expressed from a Recombinant Vaccinia Virus (1986)
    M. P. Kieny, G Rautmann et al. Nature Biotechnology
  3. Improved antigenicity of the HIV env protein by cleavage site removal (1988)
    Richard Lathe, Yves Rivière et al. Protein Engineering Design and Selection
  4. HIV-1 Core Proteins Expressed from Recombinant Vaccinia Viruses (1989)
    G Rautmann, Marie Paule Kiény et al. AIDS Research and Human Retroviruses

Citation Impact

Citing Papers

Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
2011
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Expression of HIV-1 Envelope Glycoproteins by Semliki Forest Virus Vectors
1993
Purification and Characterization of Recombinant Cystic Fibrosis Transmembrane Conductance Regulator from Chinese Hamster Ovary and Insect Cells
1995
Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR)
1992
HIV-1 rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA
1991 StandoutNobel
Cell-Mediated Immune Proliferative Responses to HIV-1 of Chimpanzees Vaccinated with Different Vaccinia Recombinant Viruses
1989 StandoutNobel
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast
1995 StandoutNobel
The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization
1989
Isotypic Restriction of the Antibody Response to Human Immunodeficiency Virus
1988 StandoutNobel
Generation and characterization of a ΔF508 cystic fibrosis mouse model
1995 StandoutNobel
Effects of the ?F508 mutation on the structure, function, and folding of the first nucleotide-binding domain of CFTR
1993
Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules
2006
Identification of the residues in human CD4 critical for the binding of HIV
1989 StandoutNobel
The bile acid synthetic gene 3β-hydroxy-Δ5-C27-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis
2000
Antibodies to the nef Protein and to nef Peptides in HIV-1—Infected Seronegative Individuals
1989 StandoutNobel
Human Cytomegalovirus Binding to DC-SIGN Is Required for Dendritic Cell Infection and Target Cell trans-Infection
2002
Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
1992 Nature
An Intracellular Trafficking Defect in Type I Cystinuria rBAT Mutants M467T and M467K
1997
Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
1993
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
1998 StandoutNobel
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas
2010 StandoutNobel
Mislocalization of ΔF508 CFTR in cystic fibrosis sweat gland
1992
The cystic fibrosis mutation (ΔF508) does not influence the chloride channel activity of CFTR
1993
Salmonella typhi uses CFTR to enter intestinal epithelial cells
1998 StandoutNatureNobel
Conformational and Temperature-sensitive Stability Defects of the ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator in Post-endoplasmic Reticulum Compartments
2001
Identification and Characterization of a Mouse Oxysterol 7α-Hydroxylase cDNA
1997
HIV as the cause of AIDS
1996 StandoutNobel
MEC-2 regulates C. elegans DEG/ENaC channels needed for mechanosensation
2002 StandoutNatureNobel
Cystic fibrosis: molecular biology and therapeutic implications
1992 StandoutScience
Sendai virus‐based expression of HIV‐1 gp120: reinforcement by the V(−) version
1997
Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro.
1997
Single amino-acid changes in HIV envelope affect viral tropism and receptor binding
1989 StandoutNatureNobel
Large fragments of nef‐protein and gp110 envelope glycoprotein from HIV‐1
1990 StandoutNobel
Degradation of CFTR by the ubiquitin-proteasome pathway
1995 Standout
From Brain to Bile
2001
Regulation by HIV Rev depends upon recognition of splice sites
1989 StandoutNobel
Mucins in cancer: protection and control of the cell surface
2003
Immunogenicity of the Human Immunodeficiency Virus (HIV) Recombinant nef Gene Product. Mapping of T-Cell and B-Cell Epitopes in Immunized Chimpanzees
1990
A mouse model for the delta F508 allele of cystic fibrosis.
1995 StandoutNobel
Functions of the auxiliary gene products of the human immunodeficiency virus type 1
1990
The spectrum of cystic fibrosis mutations
1992
Membrane Expression of HIV Envelope Glycoproteins Triggers Apoptosis in CD4 Cells
1993
Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy
1993 StandoutNatureNobel
Mysteries of HIV: challenges for therapy and prevention
1988 Nature
Regulation of bile acid synthesis
1998
Regulatory pathways governing HIV-1 replication
1989
Differential Localization of the Cystic Fibrosis Transmembrane Conductance Regulator in Normal and Cystic Fibrosis Airway Epithelium
1992
Retroviruses
1988 Science
An Animal Model for Cystic Fibrosis Made by Gene Targeting
1992 StandoutScienceNobel
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
1991 StandoutNobel
Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor.
1989
Regulation of human immunodeficiency virus env expression by the rev gene product
1989
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia.
1992
Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation
1992
Defective propeptide processing of blood clotting factor IX caused by mutation of arginine to glutamine at position −4
1986
Regulation of HIV and HTLV gene expression.
1988
Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication.
1988 StandoutNobel
Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding
1989 StandoutNobel
Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter.
1989 StandoutNobel
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
2003 Standout
Defective Epithelial Chloride Transport in a Gene-Targeted Mouse Model of Cystic Fibrosis
1992 StandoutScienceNobel
The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells.
1993
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis
2014
Lipid modification of proteins and its relevance to protein targeting
1990
Relevance of anti-nef antibody detection as an early serologic marker of human immunodeficiency virus infection
1990 StandoutNobel
Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor
1987
Bacterial Biofilms: A Common Cause of Persistent Infections
1999 StandoutScience
Oxysterols: Modulators of Cholesterol Metabolism and Other Processes
2000
Alphavirus-based expression vectors: strategies and applications.
1996 StandoutNobel
Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins.
1994
Cystic ibrosis: Molecular Biology and Therapeutic Implications
1992 Science
Expression of the art/trs Protein of HIV and Study of Its Role in Viral Envelope Synthesis
1987 Science
Pathogenesis of human immunodeficiency virus infection
1993
Expression of active human blood clotting factor IX in transgenic mice: use of a cDNA with complete mRNA sequence
1987
Stoichiometry of recombinant cystic fibrosis transmembrane conductance regulator in epithelial cells and its functional reconstitution into cells in vitro.
1994
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections.
1994 StandoutNobel
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage
1998 StandoutNobel
Chemically tunable mucin chimeras assembled on living cells
2015 StandoutNobel
The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region
1989
Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro
1991
Structure and expression of the human and mouse T4 genes.
1987 StandoutNobel
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
1991
Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
1989 StandoutNobel
Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1
1995 StandoutNobel
Prohormone processing in Xenopus oocytes: characterization of cleavage signals and cleavage enzymes.
1991 StandoutNobel
Some cis- and trans-acting mutants for splicing target pre-mRNA to the cytoplasm
1989 StandoutNobel
Dendritic Cells Exposed to Human Immunodeficiency Virus Type-1 Transmit a Vigorous Cytopathic Infection to CD4 + T Cells
1992 StandoutScienceNobel
Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1.
1989 Nobel
Apoptosis in AIDS
1993 StandoutScienceNobel
A C-terminal motif found in the β 2 -adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na + /H + exchanger regulatory factor family of PDZ proteins
1998 StandoutNobel
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Altered ubiquitination and stability of aquaporin-1 in hypertonic stress
2001 StandoutNobel
Impaired cell volume regulation in intestinal crypt epithelia of cystic fibrosis mice.
1995 StandoutNobel
Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160
1992 StandoutNobel
Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins
1989 StandoutNobel
LAV Revisited: Origins of the Early HIV-1 Isolates from Institut Pasteur
1991 StandoutScienceNobel
Fragments of the HIV-1 Tat Protein Specifically Biand TAR RNA
1990 StandoutScienceNobel
Receptor regulation of G-protein palmitoylation.
1994 StandoutNobel
Production and characterisation of monoclonal and polyclonal antibodies to different regions of the cystic fibrosis transmembrane conductance regulator (cftr): Detection of immunologically related proteins
1995
Differential acidic pH sensitivity of delta F508 CFTR Cl- channel activity in lipid bilayers
1994

Works of Karin Dott being referenced

Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation
1991 Nature
HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product
1987 StandoutNatureNobel
HIV-1 Core Proteins Expressed from Recombinant Vaccinia Viruses
1989 StandoutNobel
Mutational analysis of the HIV nef protein
1990
Neurosteroid Hydroxylase CYP7B
2001
Immunogenicity of HILDA/LIF either in a Soluble or in a Membrane Anchored Form expressed In Vivo by Recombinant Vaccinia Viruses
1993
AIDS virus env Protein Expressed from a Recombinant Vaccinia Virus
1986 StandoutNobel
A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein
1991
Active γ-carboxylated human factor IX expressed using recombinant DNA techniques
1985 Nature
Recombinant MUC 1 vaccinia virus: a potential vector for immunotherapy of breast cancer.
1994
Improved antigenicity of the HIV env protein by cleavage site removal
1988 StandoutNobel
Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7α-hydroxy dehydroepiandrosterone and 7α-hydroxy pregnenolone
1997
Rankless by CCL
2026